SCAL Stock: Stem Cell Authority, Ltd. Stock Price, Analysis & Insights
Get live SCAL stock price $0.00, comprehensive Stem Cell Authority, Ltd. stock analysis, charts, news, and expert forecast. Real-time SCAL stock data and investment insights.
Loading chart data...
Stem Cell Authority, Ltd. (SCAL) Overview
Stem Cell Authority, Ltd. (SCAL) is a publicly traded company in the Healthcare sector , specifically within the Medical - Care Facilities industry . As of the latest trading session, SCAL trades at $0.00 with a market capitalization of 17.42K . Over the past 52 weeks, SCAL has traded between $0.00 and $0.00 , with the current price positioned at approximately 100% of this range . The stock cur...
Key Takeaways
- Operates in the Healthcare sector (Medical - Care Facilities)
- Market cap: 17.42K
- Current price: $0.00
- 52-week range: $0.00 - $0.00
- P/E ratio: 0.04
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Stem Cell Authority, Ltd. (SCAL) is a technology innovation firm primarily focused on the retrieval and cryogenic storage of stem cells. The company excels at collecting and banking two specific types of stem cells: hematopoietic stem cells, sourced ...
Company Information
- CEO
- Carlzo Bernard Cardwell
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- N/A
Contact Information
- Address
- 123 South Miller Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 0.0)
✓ Lower volatility stock (Beta: 0.71) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Stem Cell Authority, Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Stem Cell Authority, Ltd.
- ⚠Investors should consider how Stem Cell Authority, Ltd. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
17.42K
P/E Ratio (TTM)
0.04
Beta
0.71
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare SCAL with peer companies:
- Price
- $0.00
- Market cap
- 5.25K
- Price
- $0.00
- Market cap
- 8.55K
- Price
- $0.00
- Market cap
- 18.44K
- Price
- $0.00
- Market cap
- 1.81K
- Price
- $0.00
- Market cap
- 8.67K
- Price
- $0.00
- Market cap
- 243.86K
- Price
- $0.00
- Market cap
- 19.68K
- Price
- $0.00
- Market cap
- 8.73K
- Price
- $0.00
- Market cap
- 16.83K
- Price
- $0.00
- Market cap
- 18.34K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.